Immunogenetics of prostate cancer and benign hyperplasia – the potential use of an HLA‐G variant as a tag SNP for prostate cancer risk

Publisher： John Wiley & Sons Inc

E-ISSN： 2059-2310|87|2|79-88

ISSN： 2059-2302

Source： HLA, Vol.87, Iss.2, 2016-02, pp. : 79-88

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Osteopontin Expression in Prostate Cancer and Benign Prostatic Hyperplasia

By  

Urologia Internationalis, Vol. 62, Iss. 3, 1999-10 ,pp. : 155-158

Karger

Access to resources Recommend Favorite

Oxidative Stress in Benign Prostatic Hyperplasia and Prostate Cancer

By  

Urologia Internationalis, Vol. 85, Iss. 3, 2010-05 ,pp. : 328-333

Karger

Access to resources Recommend Favorite

Gleason Score 6 - Prostate Cancer or Benign Variant?

By  

Oncology Research and Treatment, Vol. 38, Iss. 12, 2015-0 ,pp. : 629-632

Karger

Access to resources Recommend Favorite

Significance of Vitamin D Receptor Gene Polymorphism for Risk and Disease Severity of Prostate Cancer and Benign Prostatic Hyperplasia in Japanese

By  

Urologia Internationalis, Vol. 68, Iss. 4, 2002-05 ,pp. : 226-231

Karger

Access to resources Recommend Favorite

Cytokeratin 8/18 Levels in Patients with Prostate Cancer and Benign Prostatic Hyperplasia

By  

Urologia Internationalis, Vol. 60, Iss. 3, 1998-06 ,pp. : 152-155

Karger

Access to resources Recommend Favorite